CDK13 and cancer: To examine the function of CDK13 and how its expression affects the main cancer hallmarks in thyroid cancer, we performed loss-of-function assays using three independent siRNAs that markedly decreased CDK13 RNA and protein levels in Cal62 and TPC1 thyroid cancer cells (Fig. 4A, B).